These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29133890)

  • 1. Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.
    Zakerska-Banaszak O; Skrzypczak-Zielinska M; Tamowicz B; Mikstacki A; Walczak M; Prendecki M; Dorszewska J; Pollak A; Lechowicz U; Oldak M; Huminska-Lisowska K; Molinska-Glura M; Szalata M; Slomski R
    Sci Rep; 2017 Nov; 7(1):15399. PubMed ID: 29133890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.
    Mikstacki A; Zakerska-Banaszak O; Skrzypczak-Zielinska M; Tamowicz B; Prendecki M; Dorszewska J; Molinska-Glura M; Waszak M; Slomski R
    J Appl Genet; 2017 May; 58(2):213-220. PubMed ID: 27826892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment.
    Khan MS; Zetterlund EL; Gréen H; Oscarsson A; Zackrisson AL; Svanborg E; Lindholm ML; Persson H; Eintrei C
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):565-70. PubMed ID: 24891132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece.
    Mastrogianni O; Gbandi E; Orphanidis A; Raikos N; Goutziomitrou E; Kolibianakis EM; Tarlatzis BC; Goulas A
    Drug Metab Pharmacokinet; 2014; 29(2):215-8. PubMed ID: 24153159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.
    Kanaya A; Sato T; Fuse N; Yamaguchi H; Mano N; Yamauchi M
    J Anesth; 2018 Apr; 32(2):236-243. PubMed ID: 29468507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability.
    Mourão AL; de Abreu FG; Fiegenbaum M
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):511-5. PubMed ID: 26141406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of
    Alrabayah M; Massad IM; Imraish A; Jarrar Y; Massad F; Guzu H; Abufares B; Al-Oran A; Alkharabsheh MM; Haroon N; Ismail MA; Qaqish B; Zihlif M
    Curr Drug Metab; 2023; 23(14):1156-1161. PubMed ID: 36717987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis.
    Yonekura H; Murayama N; Yamazaki H; Sobue K
    A A Case Rep; 2016 Dec; 7(11):243-246. PubMed ID: 27749294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Potential Gene Polymorphisms on Propofol Dosage Regimen in Patients Undergoing Abdominal Hysterectomy.
    Ivanov E; Sterjev Z; Budic I; Nojkov J; Karadzova D; Sivevski A
    Balkan J Med Genet; 2020 Nov; 23(2):41-48. PubMed ID: 33816071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PharmGKB summary: Efavirenz pathway, pharmacokinetics.
    McDonagh EM; Lau JL; Alvarellos ML; Altman RB; Klein TE
    Pharmacogenet Genomics; 2015 Jul; 25(7):363-76. PubMed ID: 25966836
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.
    Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Jiang-Zheng C; Koller D; Mejía G; Zubiaur P; Wojnicz A; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):474-485. PubMed ID: 29723928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia.
    Iohom G; Ni Chonghaile M; O'Brien JK; Cunningham AJ; Fitzgerald DF; Shields DC
    Eur J Anaesthesiol; 2007 Nov; 24(11):912-9. PubMed ID: 17555608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement.
    Ferrari M; Tozzi M; Marino F; Tarallo A; Riva F; Mirabile M; Castelli P; Cosentino M
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):46-48. PubMed ID: 30531616
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
    Gallien S; Journot V; Loriot MA; Sauvageon H; Morlat P; Reynes J; Reliquet V; Chêne G; Molina JM;
    HIV Med; 2017 Sep; 18(8):537-545. PubMed ID: 28145050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.
    Evans J; Swart M; Soko N; Wonkam A; Huzair F; Dandara C
    OMICS; 2015 Jun; 19(6):332-8. PubMed ID: 26415139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.
    Dhoro M; Zvada S; Ngara B; Nhachi C; Kadzirange G; Chonzi P; Masimirembwa C
    BMC Pharmacol Toxicol; 2015 Mar; 16():4. PubMed ID: 25889207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
    Saitoh A; Sarles E; Capparelli E; Aweeka F; Kovacs A; Burchett SK; Wiznia A; Nachman S; Fenton T; Spector SA
    AIDS; 2007 Oct; 21(16):2191-9. PubMed ID: 18090046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of
    Pavlovic D; Budic I; Jevtovic Stoimenov T; Stokanovic D; Marjanovic V; Stevic M; Slavkovic M; Simic D
    Pharmgenomics Pers Med; 2020; 13():13-27. PubMed ID: 32021384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse transit time reveals drug kinetics on vascular changes affected by propofol.
    Lan YC; Shen CH; Kang HM; Chong FC
    Comput Methods Biomech Biomed Engin; 2012; 15(9):949-52. PubMed ID: 21547779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
    Court MH; Duan SX; Hesse LM; Venkatakrishnan K; Greenblatt DJ
    Anesthesiology; 2001 Jan; 94(1):110-9. PubMed ID: 11135730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.